Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Safety of placebo controls in pediatric hypertension trials.

Smith PB, Li JS, Murphy MD, Califf RM, Benjamin DK Jr.

Hypertension. 2008 Apr;51(4):829-33. doi: 10.1161/HYPERTENSIONAHA.107.104950.

2.
3.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Review.

PMID:
25236305
4.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
5.

Cochrane in context: pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.

Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Review.

PMID:
25236306
6.

Medicine. Placebo-controls in short-term clinical trials of hypertension.

Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J.

Science. 2001 Jun 15;292(5524):2013-5. Review. No abstract available.

PMID:
11408643
7.

The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis.

DeFelice A, Willard J, Lawrence J, Hung J, Gordon MA, Karkowsky A, Targum S, Throckmorton DC, Girton J, Stertz B, Glasser SP, Lipicky RJ.

J Hum Hypertens. 2008 Oct;22(10):659-68. doi: 10.1038/jhh.2008.51.

PMID:
18528409
8.

Trials of antihypertensive therapies in children.

Wells TG.

Blood Press Monit. 1999 Jun-Aug;4(3-4):189-92. Review.

PMID:
10490874
9.

Pediatric antihypertensive trial failures: analysis of end points and dose range.

Benjamin DK Jr, Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS.

Hypertension. 2008 Apr;51(4):834-40. doi: 10.1161/HYPERTENSIONAHA.107.108886.

10.

Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.

Potter J, Mistri A, Brodie F, Chernova J, Wilson E, Jagger C, James M, Ford G, Robinson T.

Health Technol Assess. 2009 Jan;13(9):iii, ix-xi, 1-73. doi: 10.3310/hta13090.

11.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
12.

Pharmacological interventions for hypertensive emergencies.

Perez MI, Musini VM.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003653. doi: 10.1002/14651858.CD003653.pub3. Review.

PMID:
18254026
14.

Clevidipine: a review of its use in the management of acute hypertension.

Deeks ED, Keating GM, Keam SJ.

Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006. Review.

PMID:
19331440
15.

Manidipine: a review of its use in hypertension.

Cheer SM, McClellan K.

Drugs. 2001;61(12):1777-99. Review.

PMID:
11693466
16.

Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trials.

Sucharew H, Goss CH, Millard SP, Ramsey BW; Cystic Fibrosis Therapeutics Development Network..

Contemp Clin Trials. 2006 Dec;27(6):561-70.

PMID:
16875884
17.
18.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
19.

Short-term trials and long-term effects.

Daniels SR.

Science. 2001 Sep 28;293(5539):2392-4. No abstract available.

PMID:
11579936
20.

Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.

Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, Francis DP, di Mario C.

Hypertension. 2015 Feb;65(2):401-6. doi: 10.1161/HYPERTENSIONAHA.114.04640.

Supplemental Content

Support Center